|
"Long
before it's in the papers"
November 01, 2011
RETURN
TO THE WORLD SCIENCE HOME PAGE
Wine ingredient may help men cheat some of
obesity’s effects
Nov. 1, 2011
Courtesy of Cell Press
and World
Science staff
When obese men take a fairly small dose of the red wine ingredient resveratrol every day for a month, their metabolisms improve, a study has found.
The substance had also been found to increase lifespan in some animal models, but the jury is out on whether it has comparable effects in people.
In obese men, its metabolic effects appear to be as good as those of severe calorie restriction, a sharp cutback in eating also associated with increased lifespan, the researchers said. “We saw a lot of small effects, but consistently pointing in a good direction of improved metabolic health” with resveratrol, said Patrick Schrauwen of Maastricht University in The Netherlands.
The findings, published in the November issue of the journal Cell Metabolism, are billed as the first to report the clinical effects of the increasingly trendy supplement.
Earlier studies in animals had shown that resveratrol protects against the ill effects of a fatty diet and the symptoms of diabetes, Schrauwen said. Still, no studies had systematically examined the metabolic effects of resveratrol in humans. To fill that gap, the researchers gave 11 obese but otherwise healthy men a dietary supplement containing 150 milligrams of a 99 percent pure resveratrol (trade name resVida) for 30 days while they measured the amount of energy they expended, the amount of fat they were storing and burning, and more.
The data show that, like calorie restriction, resveratrol supplements lower energy expenditure and improve measures of metabolism and overall health, Schrauwen and colleagues said. Those changes include a lower metabolic rate, less fat in the liver, lower blood sugar levels and a drop in blood pressure. Trial participants also experienced changes in the way their muscles burned fat.
“The immediate reduction in sleep metabolic rate was particularly striking,” Schrauwen said.
In the case of obesity, it’s not totally clear whether burning fewer calories is a good or a bad
thing, he added, but the findings do suggest that participants’ cells were operating more efficiently, as they do following calorie restriction.
Those metabolic effects of resveratrol also came with no apparent side effects, according to the report.
Schrauwen said they chose to study obese people given their increased risk for type 2 diabetes. In future studies, he hopes to explore the effects of resveratrol in people who have already progressed to diabetes. Resveratrol supplements are widely available, but more work is needed to establish whether they indeed have the potential to overcome the metabolic aberrations associated with obesity and aging, according to the researchers. “I don’t see a reason for particular caution, but we do need long-term studies,” Schrauwen said.
* * *
Send us a comment
on this story, or send
it to a friend
|
|
|
On
Home Page
LATEST
Planets may be smashed to dust near black holes
Global warming already causes some droughts, scientists say
EXCLUSIVES
-
Tiny bugs have own personalities despite being clones, scientists say
-
Does a smile mean something to a dog?
-
Why do men use silly pickup lines?
-
Bars may kill spiral galaxies
MORE NEWS
-
Related genes may promote human music, bird song
-
Explosion shutting down a galactic party: physicists
-
“King” of dinos called more hyena than lion
|
|
|
|
|
|
|
|
|
When obese men take a fairly small dose of the red wine ingredient resveratrol every day for a month, their metabolisms improve, a study has found.
The substance had also been found to increase lifespan in some animal models, but the jury is out on whether it has comparable effects in people.
In obese men, its metabolic effects appear to be as good as those of severe calorie restriction, a sharp cutback in eating also associated with increased lifespan, the researchers said. “We saw a lot of small effects, but consistently pointing in a good direction of improved metabolic health” with resveratrol, said Patrick Schrauwen of Maastricht University in The Netherlands.
The findings, published in the November issue of the Cell Press journal Cell Metabolism, are billed as the first to report the clinical effects of the increasingly trendy supplement.
Earlier studies in animals had shown that resveratrol protects against the ill effects of a fatty diet and the symptoms of diabetes, Schrauwen said. Still, no studies had systematically examined the metabolic effects of resveratrol in humans. To fill that gap, the researchers gave 11 obese but otherwise healthy men a dietary supplement containing 150 milligrams of a 99 percent pure resveratrol (trade name resVida) for 30 days while they measured the amount of energy they expended, the amount of fat they were storing and burning, and more.
The data show that, like calorie restriction, resveratrol supplements lower energy expenditure and improve measures of metabolism and overall health, Schrauwen and colleagues said. Those changes include a lower metabolic rate, less fat in the liver, lower blood sugar levels and a drop in blood pressure. Trial participants also experienced changes in the way their muscles burned fat.
“The immediate reduction in sleep metabolic rate was particularly striking,” Schrauwen said. Of course, in the case of obesity, it’s not totally clear whether burning fewer calories is a good or a bad thing. It does suggest that participants’ cells were operating more efficiently, as they do following calorie restriction, he explained.
Those metabolic effects of resveratrol also came with no apparent side effects, according to the report.
Schrauwen said they chose to study obese individuals given their increased risk for type 2 diabetes. In future studies, he hopes to explore the effects of resveratrol in people who have already progressed to diabetes. Resveratrol supplements are widely available, but more work is needed to establish whether they indeed have the potential to overcome the metabolic aberrations associated with obesity and aging, according to the researchers. “I don’t see a reason for particular caution, but we do need long-term studies,” Schrauwen said.
|